Shree Pacetronix Ltd
Incorporated in 1988, Shree Pacetronix Ltd
is in the business of trading of Pacemakers.[1]
- Market Cap ₹ 48.8 Cr.
- Current Price ₹ 130
- High / Low ₹ 283 / 66.1
- Stock P/E 19.7
- Book Value ₹ 42.9
- Dividend Yield 0.00 %
- ROCE 9.12 %
- ROE 5.59 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 31.7%
- Debtor days have increased from 102 to 145 days.
- Working capital days have increased from 108 days to 158 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.00 | 6.89 | 7.44 | 6.94 | 6.80 | 7.28 | 8.77 | 7.56 | 9.23 | 20.26 | 22.04 | 16.68 | 20.54 | |
| 6.60 | 5.86 | 6.37 | 6.39 | 5.88 | 6.50 | 7.57 | 6.62 | 7.45 | 14.81 | 16.16 | 14.34 | 15.96 | |
| Operating Profit | 1.40 | 1.03 | 1.07 | 0.55 | 0.92 | 0.78 | 1.20 | 0.94 | 1.78 | 5.45 | 5.88 | 2.34 | 4.58 |
| OPM % | 17.50% | 14.95% | 14.38% | 7.93% | 13.53% | 10.71% | 13.68% | 12.43% | 19.28% | 26.90% | 26.68% | 14.03% | 22.30% |
| 0.01 | 0.03 | 0.02 | 0.05 | 0.01 | 0.17 | 0.04 | 0.05 | 0.07 | 0.10 | 0.14 | 0.12 | 0.10 | |
| Interest | 0.47 | 0.42 | 0.37 | 0.40 | 0.32 | 0.32 | 0.38 | 0.35 | 0.29 | 0.30 | 0.45 | 0.61 | 0.50 |
| Depreciation | 0.60 | 0.76 | 0.77 | 0.65 | 0.42 | 0.38 | 0.51 | 0.51 | 0.50 | 0.63 | 0.95 | 0.81 | 0.74 |
| Profit before tax | 0.34 | -0.12 | -0.05 | -0.45 | 0.19 | 0.25 | 0.35 | 0.13 | 1.06 | 4.62 | 4.62 | 1.04 | 3.44 |
| Tax % | 32.35% | -58.33% | 60.00% | -26.67% | 31.58% | 44.00% | 31.43% | 61.54% | 26.42% | 29.44% | 27.49% | 27.88% | |
| 0.23 | -0.06 | -0.09 | -0.32 | 0.13 | 0.14 | 0.24 | 0.05 | 0.78 | 3.26 | 3.36 | 0.75 | 2.48 | |
| EPS in Rs | 0.64 | -0.17 | -0.25 | -0.89 | 0.36 | 0.39 | 0.67 | 0.14 | 2.17 | 9.06 | 9.33 | 2.08 | 6.88 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 22% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 27% |
| 3 Years: | 0% |
| TTM: | 44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 64% |
| 3 Years: | 8% |
| 1 Year: | 89% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | 22% |
| Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
| Reserves | 1.86 | 1.77 | 1.68 | 1.36 | 1.60 | 1.74 | 1.98 | 2.03 | 2.81 | 6.07 | 9.43 | 10.18 | 12.16 |
| 2.14 | 2.78 | 1.97 | 2.71 | 2.93 | 3.91 | 3.33 | 3.20 | 3.05 | 2.19 | 4.30 | 5.08 | 5.05 | |
| 1.38 | 0.95 | 1.35 | 1.16 | 1.33 | 1.35 | 2.08 | 2.15 | 2.72 | 4.68 | 4.42 | 4.19 | 4.56 | |
| Total Liabilities | 8.98 | 9.10 | 8.60 | 8.83 | 9.46 | 10.60 | 10.99 | 10.98 | 12.18 | 16.54 | 21.75 | 23.05 | 25.37 |
| 3.42 | 3.13 | 2.55 | 2.02 | 1.88 | 2.40 | 2.47 | 2.69 | 2.56 | 3.12 | 4.24 | 3.87 | 3.67 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.77 | 0.99 | 1.25 | 1.81 | 1.64 | 1.65 | 1.66 | 0.93 | 0.93 | 0.93 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 5.56 | 5.97 | 6.05 | 6.04 | 6.59 | 6.95 | 6.71 | 6.65 | 7.97 | 11.76 | 16.58 | 18.25 | 20.77 | |
| Total Assets | 8.98 | 9.10 | 8.60 | 8.83 | 9.46 | 10.60 | 10.99 | 10.98 | 12.18 | 16.54 | 21.75 | 23.05 | 25.37 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.06 | 0.47 | 1.35 | 0.42 | 1.13 | 0.31 | 2.25 | 1.09 | 1.76 | 1.69 | -0.04 | -0.01 | |
| -0.44 | -0.49 | -0.18 | -0.86 | -0.52 | -1.01 | -1.00 | -0.53 | -1.19 | -1.41 | -1.67 | -0.04 | |
| -0.85 | 0.20 | -1.14 | 0.22 | -0.50 | 0.36 | -1.17 | -0.31 | -0.45 | -1.10 | 1.75 | 0.19 | |
| Net Cash Flow | -0.23 | 0.18 | 0.03 | -0.22 | 0.10 | -0.34 | 0.08 | 0.25 | 0.12 | -0.82 | 0.04 | 0.14 |
| Free Cash Flow | 0.61 | -0.02 | 1.15 | -0.46 | 0.63 | -0.72 | 1.13 | 0.53 | 1.42 | 0.49 | -1.38 | -0.73 |
| CFO/OP | 80% | 54% | 126% | 98% | 123% | 45% | 192% | 135% | 106% | 48% | 19% | 47% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86.23 | 70.99 | 88.31 | 113.08 | 143.32 | 152.92 | 134.01 | 145.81 | 127.73 | 84.85 | 77.17 | 145.08 |
| Inventory Days | 443.76 | 670.58 | 359.32 | 243.33 | 301.93 | 276.44 | 216.62 | 272.02 | 194.20 | 157.41 | 285.83 | 463.17 |
| Days Payable | 48.46 | 29.71 | 32.67 | 18.86 | 49.65 | 37.10 | 54.15 | 48.57 | 17.55 | 32.22 | 12.45 | 57.32 |
| Cash Conversion Cycle | 481.52 | 711.86 | 414.96 | 337.55 | 395.60 | 392.26 | 296.48 | 369.25 | 304.38 | 210.04 | 350.55 | 550.93 |
| Working Capital Days | 89.88 | 107.01 | 116.27 | 110.97 | 107.35 | 100.27 | 42.87 | 37.66 | 23.33 | 63.06 | 101.68 | 157.77 |
| ROCE % | 10.53% | 3.56% | 4.16% | -0.80% | 6.46% | 5.06% | 7.93% | 5.30% | 14.43% | 46.15% | 34.74% | 9.12% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Mar 2027 (P) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and Development (R&D) Expenditure INR ・Standalone data |
|
|||||||||
| Debtors Turnover Ratio Ratio ・Standalone data |
||||||||||
| Number of Permanent Employees Count |
||||||||||
| Cumulative Pacemaker Implants Units ・Standalone data |
||||||||||
| Planned Capex for Capacity Upgrade/Automation INR Lakhs ・Standalone data |
||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
||||||||||
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
2d - In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018, please find enclosed herewith the certificate received from the Registrar and Share …
-
Reply To Clarification On Price Movement Sought By BSE Limited Dated 09.04.2026
2d - Company replied to BSE that recent share price movement is market-driven.
-
Clarification sought from Shree Pacetronix Ltd
10 Apr - Exchange has sought clarification from Shree Pacetronix Ltd on April 9, 2026 with reference to significant movement in price, in order to ensure that investors …
- Closure of Trading Window 26 Mar
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 24 Mar
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
SPL is in the business of delivering MRI safe life saving critical medical devices that regulate heart rhythms and improve the quality of life for patients suffering from cardiac conditions
such as arrhythmias and heart failure.